Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report by State

Liver & Bile Duct (Late Stage^), 2013-2017

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by CI*Rank
State
 sort alphabetically by name ascending
Met Healthy People Objective of ***?
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate descending
CI*Rank⋔
(95% Confidence Interval)
 sort by CI rank descending
Average Annual Count
 sort by count descending
Percent of Cases with Late Stage
 sort by percent late descending
US (SEER+NPCR) 1 *** 3.6 (3.5, 3.6) N/A 14,051 42.1
Texas 6 *** 4.5 (4.4, 4.6) 1 (1, 5) 1,291 38.4
Louisiana 3 *** 4.5 (4.3, 4.8) 2 (1, 6) 258 45.2
Hawaii 3 *** 4.4 (4.0, 4.9) 3 (1, 15) 81 39.0
District of Columbia 6 *** 4.2 (3.5, 5.0) 4 (1, 32) 29 34.4
Mississippi 6 *** 4.2 (3.9, 4.5) 5 (1, 17) 150 47.3
Delaware 6 *** 4.1 (3.6, 4.6) 6 (1, 29) 52 45.8
Georgia 3 *** 4.0 (3.9, 4.2) 7 (3, 14) 467 49.8
New York 3 *** 4.0 (3.9, 4.1) 8 (4, 14) 972 43.7
North Carolina 6 *** 4.0 (3.8, 4.1) 9 (4, 16) 492 46.2
Kentucky 3 *** 3.9 (3.7, 4.2) 10 (3, 20) 220 46.6
California 3 *** 3.9 (3.8, 4.0) 11 (6, 16) 1,702 39.4
Pennsylvania 6 *** 3.8 (3.7, 4.0) 12 (5, 19) 662 44.5
Alaska 6 *** 3.8 (3.1, 4.5) 13 (1, 42) 28 41.4
Maryland 6 *** 3.8 (3.6, 4.0) 14 (5, 24) 275 42.7
Washington 5 *** 3.8 (3.6, 3.9) 15 (6, 24) 329 41.3
Oregon 6 *** 3.7 (3.5, 3.9) 16 (6, 28) 199 39.7
West Virginia 6 *** 3.7 (3.4, 4.0) 17 (4, 34) 96 48.8
Missouri 6 *** 3.7 (3.5, 3.9) 18 (8, 27) 284 46.9
Connecticut 3 *** 3.6 (3.4, 3.9) 19 (7, 33) 170 45.2
Massachusetts 3 *** 3.6 (3.4, 3.8) 20 (11, 30) 307 44.5
Wisconsin 6 *** 3.5 (3.4, 3.8) 21 (12, 31) 260 49.6
South Carolina 6 *** 3.5 (3.3, 3.7) 22 (13, 35) 222 43.1
Tennessee 6 *** 3.5 (3.3, 3.6) 23 (14, 33) 289 41.0
Arkansas 6 *** 3.5 (3.2, 3.7) 24 (11, 36) 130 44.2
Rhode Island 6 *** 3.4 (3.0, 3.9) 25 (5, 42) 47 40.2
Illinois 6 *** 3.4 (3.2, 3.5) 26 (18, 34) 520 43.9
Florida 6 *** 3.3 (3.2, 3.4) 27 (22, 34) 961 42.4
Indiana 6 *** 3.3 (3.1, 3.5) 28 (19, 37) 269 46.1
Minnesota 6 *** 3.3 (3.1, 3.5) 29 (18, 38) 219 44.8
New Jersey 3 *** 3.3 (3.2, 3.5) 30 (20, 37) 365 42.1
New Mexico 3 *** 3.3 (3.0, 3.6) 31 (14, 42) 87 32.0
Idaho 3 *** 3.3 (2.9, 3.6) 32 (13, 43) 65 44.2
Iowa 3 *** 3.2 (3.0, 3.5) 33 (17, 41) 126 47.0
Virginia 6 *** 3.1 (2.9, 3.3) 34 (27, 41) 313 42.1
Oklahoma 6 *** 3.1 (2.9, 3.3) 35 (23, 43) 148 37.5
Colorado 6 *** 3.1 (2.9, 3.3) 36 (26, 43) 189 41.0
Ohio 6 *** 3.0 (2.9, 3.1) 37 (31, 42) 450 41.4
South Dakota 6 *** 3.0 (2.5, 3.5) 38 (14, 49) 31 43.0
Kansas 6 *** 3.0 (2.7, 3.2) 39 (25, 45) 104 43.1
Michigan 5 *** 2.9 (2.8, 3.1) 40 (33, 44) 383 41.4
Utah 3 *** 2.8 (2.5, 3.1) 41 (32, 49) 74 44.8
Arizona 6 *** 2.8 (2.6, 2.9) 42 (37, 47) 236 34.7
Montana 6 *** 2.7 (2.3, 3.2) 43 (28, 51) 39 42.1
Alabama 6 *** 2.6 (2.5, 2.8) 44 (39, 49) 165 34.2
North Dakota 6 *** 2.5 (2.0, 3.0) 45 (30, 51) 21 53.8
Nebraska 6 *** 2.5 (2.2, 2.8) 46 (39, 51) 56 43.0
Maine 6 *** 2.5 (2.2, 2.8) 47 (38, 51) 50 44.9
New Hampshire 6 *** 2.4 (2.1, 2.8) 48 (39, 51) 44 38.4
Vermont 6 *** 2.4 (1.9, 2.9) 49 (35, 51) 20 42.9
Wyoming 6 *** 2.3 (1.8, 2.9) 50 (34, 51) 17 37.2
Nevada 6 *** 2.2 (2.0, 2.4) 51 (45, 51) 77 31.7
Puerto Rico 6 *** 2.0 (1.8, 2.2) N/A 94 24.1
Notes:
Created by statecancerprofiles.cancer.gov on 04/21/2021 9:11 am.

State Cancer Registries may provide more current or more local data.
Trend
Rising when 95% confidence interval of average annual percent change is above 0.
Stable when 95% confidence interval of average annual percent change includes 0.
Falling when 95% confidence interval of average annual percent change is below 0.

⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The 1969-2017 US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Coding is generally based on Surveillance, Epidemiology, and End Results (SEER) summary stage but may include other staging variables if necessary.
*** No Healthy People 2020 Objective for this cancer.
Healthy People 2020 Objectives provided by the Centers for Disease Control and Prevention.


1 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database (2001-2017) - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2019 submission.
3 Source: SEER November 2019 submission. State Cancer Registry also receives funding from CDC's National Program of Cancer Registries.
5 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database (2001-2017) - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2019 submission.
6 Source: National Program of Cancer Registries SEER*Stat Database (2001-2017) - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2019 submission).

Interpret Rankings provides insight into interpreting cancer incidence statistics. When the population size for a denominator is small, the rates may be unstable. A rate is unstable when a small change in the numerator (e.g., only one or two additional cases) has a dramatic effect on the calculated rate.

Data for United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.

Return to Top